Search

everythinglearnresearchcommunity

for

Search:↓

Some dermatologists in Saudi Arabia prescribe Tofacitinib for hair loss, but many don't due to its unavailability and safety concerns.

Non-invasive methods can effectively diagnose and manage alopecia areata.

Both DPCP alone and with PRP are effective and safe for treating severe alopecia areata.

People with alopecia areata have similar retinal structures but thicker choroidal regions compared to those without the condition.

Different types of hair loss require specific treatments, and new treatments are being developed.

Patients with alopecia areata face challenges accessing Janus kinase inhibitors, but some see positive results.

Baricitinib was effective and safe for severe hair loss treatment over 6 months.

Some multiple sclerosis treatments may trigger hair loss conditions like alopecia areata.

Congenital alopecia areata may have genetic links and topical corticosteroids are an effective treatment.

Baricitinib was effective in treating severe and very severe alopecia areata after 52 weeks.

A woman's rare hair loss condition improved on its own, suggesting this type might recover like common cases.

Alopecia areata causes hair loss and life quality issues; current treatments are often unsatisfactory, but new drugs like JAK inhibitors show promise.

Alopecia areata significantly impacts patients' mental health and quality of life.

The new deep learning system can accurately recognize hair loss conditions with a 95.11% success rate.

Alopecia areata has a high chance of persisting and relapsing, with a significant risk of total hair loss, especially if it starts in childhood.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

Baricitinib is a promising treatment for severe alopecia areata with minimal side effects.

Intravenous methylprednisolone helped over half of alopecia areata patients regrow hair, but many relapsed.

Too much IKZF1 and Ikaros protein may cause alopecia areata.

Cryotherapy might help regrow hair in Alopecia Areata, but more consistent research is needed.

People with Alopecia Areata are more likely to have certain health issues like ulcerative colitis and type 1 diabetes, but less likely to have others like hypertension and type 2 diabetes.

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

JAK inhibitors help hair growth by boosting beta-catenin activity in hair root cells.

The research identified unique metabolic activities in immune cells associated with hair loss in Alopecia Areata.

The study suggests that a specific type of immune cell, memory-like NK cells, may increase during active hair loss in Alopecia areata.

People with alopecia areata have fewer IL-10 producing immune cells, which might contribute to the condition.

COVID-19 reinfection may trigger alopecia areata.

There's no strong link between Alopecia Areata, a hair loss condition, and fatty liver, but more research is needed.

New research has found 14 genes linked to the risk of developing alopecia areata, improving understanding and treatment options.

New gene discoveries have improved diagnosis and treatment for skin and hair disorders, but more research is needed to fully understand them.